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Development/Plasticity/Repair

Gpr126/Adgrg6 Has Schwann Cell Autonomous and
Nonautonomous Functions in Peripheral Nerve Injury
and Repair
X Amit Mogha,1 X Breanne L. Harty,1 Dan Carlin,2 Jessica Joseph,1 Nicholas E. Sanchez,1 Ueli Suter,4 XXianhua Piao,5
Valeria Cavalli,2,3 and Kelly R. Monk1,3
1

Department of Developmental Biology, 2Department of Neuroscience, and 3Hope Center for Neurological Disorders, Washington University School of
Medicine, St. Louis, Missouri 63110, 4Institute of Molecular Health Sciences, Department of Biology, Swiss Federal Institute of Technology, Zurich, ETH
Zurich, CH-8093 Zurich, Switzerland, and 5Division of Newborn Medicine, Department of Medicine, Boston Children’s Hospital and Harvard Medical
School, Boston, Massachusetts 02115

Schwann cells (SCs) are essential for proper peripheral nerve development and repair, although the mechanisms regulating these processes are incompletely understood. We previously showed that the adhesion G protein-coupled receptor Gpr126/Adgrg6 is essential for
SC development and myelination. Interestingly, the expression of Gpr126 is maintained in adult SCs, suggestive of a function in the
mature nerve. We therefore investigated the role of Gpr126 in nerve repair by studying an inducible SC-specific Gpr126 knock-out mouse
model. Here, we show that remyelination is severely delayed after nerve-crush injury. Moreover, we also observe noncell-autonomous
defects in macrophage recruitment and axon regeneration in injured nerves following loss of Gpr126 in SCs. This work demonstrates that
Gpr126 has critical SC-autonomous and SC-nonautonomous functions in remyelination and peripheral nerve repair.
Key words: adhesion GPCR; Gpr126; nerve injury; remyelination; Schwann cell

Significance Statement
Lack of robust remyelination represents one of the major barriers to recovery of neurological functions in disease or following
injury in many disorders of the nervous system. Here we show that the adhesion class G protein-coupled receptor (GPCR)
Gpr126/Adgrg6 is required for remyelination, macrophage recruitment, and axon regeneration following nerve injury. At least
30% of all approved drugs target GPCRs; thus, Gpr126 represents an attractive potential target to stimulate repair in myelin
disease or following nerve injury.

Introduction
In the peripheral nervous system (PNS), specialized glia known as
Schwann cells (SCs) are best known for their role in generating
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the myelin sheath during development, which enables rapid action potential propagation. Yet, following nerve injury, SCs are
also vital players in repair. Axons distal to an injury site undergo
Wallerian degeneration, a programmed cellular response that
drives axon fragmentation. SCs associated with these degenerating axons also respond in a stereotyped fashion, becoming
“Büngner” or repair SCs, which are essential mediators of
nerve repair. Repair SCs downregulate the expression of genes
associated with myelination and upregulate genes associated with
immature SC stages. Further, repair SCs also upregulate neurotrophic factors and cytokines, which promote neuronal survival and macrophage recruitment, respectively (Arthur-Farraj et
al., 2012). The macrophages recruited by SCs phagocytose axon
and myelin debris, and SCs themselves also efficiently clear debris
by a specialized form of autophagy (Gomez-Sanchez et al., 2015).
Following nerve injury, axons regrow through Büngner bands—
DOI:10.1523/JNEUROSCI.3854-15.2016
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repair SC-containing basal lamina tubes— back to their targets.
Once SC–axon contact is reestablished, repair SCs differentiate
and remyelinate the regenerated axons, which is necessary to
restore optimal nerve function following repair.
Although there are some differences between developmental
myelination and remyelination following injury, many of the
same molecular programs are reinitiated during repair. For example, the transcription factors Oct-6 (Pou3f1) and Krox-20
(Egr2) are similarly expressed in both contexts, with transient
Oct-6 expression following axon contact that in turn regulates
Krox-20 and subsequent myelin gene expression (Scherer et al.,
1994; Zorick et al., 1996; Chen et al., 2007). During development,
Oct-6, Krox-20, and myelin gene expression, as well as myelination, are all downstream of Gpr126 (Adgrg6) activation in SCs
(Monk et al., 2009, 2011; Mogha et al., 2013). Gpr126 is a member
of the adhesion G protein-coupled receptor (aGPCR) class;
aGPCRs possess, in addition to a seven-transmembrane domain
that couples to heterotrimeric G-proteins, a long N-terminal region rich in functional motifs often involved in cell– cell or cell–
matrix adhesion. Most aGPCRs undergo an autocleavage event
that splits the receptor into two fragments, and recent studies
demonstrate that this autocleavage can generate a tethered agonist ligand in many aGPCRs (Liebscher et al., 2014; Demberg et
al., 2015; Stoveken et al., 2015). In the case of Gpr126, activation
by the tethered agonist is required for SC myelination (Liebscher
et al., 2014; Petersen et al., 2015), and we recently determined that
laminin-211 binds the N-terminus of Gpr126 and modulates the
availability of the tethered agonist (Petersen et al., 2015).
Despite the essential function of Gpr126 in SC development, it
is unknown whether this aGPCR is similarly required for remyelination following injury. Moreover, Gpr126 is robustly expressed in mature SCs (Mogha et al., 2013), but its function in
adult nerve is not fully understood. In the present study, we use
tamoxifen-inducible conditional mouse models to investigate
the role of Gpr126 in SCs following nerve injury. We show that
while Gpr126 is dispensable for myelin maintenance up to 4
months, this aGPCR has key SC-autonomous and SCnonautonomous functions during injury and repair. Mirroring
its role in development, we show that Gpr126 is required in SCs
for remyelination. Unexpectedly, we also find that Gpr126 is required in SCs for increased macrophage numbers in the distal
stump as well as efficient axon regeneration following injury.
Importantly, mutations in LAMA2, which encodes the ␣2 chain
of the Gpr126-binding partner laminin-211, cause merosindeficient congenital muscular dystrophy (MDC1A) in humans,
and 80% of these patients present with a dysmyelinating neuropathy (Shorer et al., 1995; Mercuri et al., 1996; Quijano-Roy et al.,
2004). Therefore, this work has important implications for repair
in MDC1A patients and potentially for other peripheral nerve
diseases as well.

Materials and Methods
Mice. All animal experiments were performed in compliance with Washington University’s institutional animal protocols. Gpr126fl/fl mice,
PLPCre-ERT2 mice, DhhCre mice, RosaLacZ mice, and genotyping assays
have been previously described (Soriano, 1999; Jaegle et al., 2003; Leone
et al., 2003; Mogha et al., 2013). For all experiments, mice of both sexes
were analyzed and we always compared littermate sibling controls.
Tamoxifen injections. For all experiments involving “icKO mice,”
PLPCre-ERT2;Gpr126fl/fl;Rosa⫹ animals were injected daily with either tamoxifen (in 9:1 sunflower oil/ethanol) to induce the Cre recombinase
activity or with solvent only (control; 9:1 sunflower oil/ethanol). We
injected animals beginning at 8 weeks of age once per day at 2 mg/ml for
5 consecutive days. For myelin maintenance experiments, we analyzed
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N ⫽ 3 control-injected and tamoxifen-injected animals 4 weeks following the final injections and N ⫽ 3 control-injected and tamoxifeninjected animals 4 months following the final injections.
Nerve crush. Sciatic nerves of right hind limbs were crushed 4 weeks
following the final control or tamoxifen injection according to standard
protocols (Akassoglou et al., 2002; Bauder and Ferguson, 2012). Briefly,
mice were anesthetized by isofluorane before and during surgery. Fur was
removed with an electric trimmer and the sciatic nerve of the right
hindlimb was exposed by making a small cut in the skin. The exposed
sciatic nerve was carefully crushed with number 5 forceps as described
previously (Bauder and Ferguson, 2012), and the crush site was marked
with powdered carbon. After crush, surgical wounds were sutured with
nylon thread and sealed with metal clips. Mice were administered painreducing chow (Bio Serv) during recovery until they were killed. We used
a minimum of N ⫽ 3 mice for control-injected and tamoxifen-injected
groups at each time point.
Nerve and muscle harvest. Following the nerve injury, sciatic nerves
were harvested at 3, 7, 21, or 35 d postinjury (dpi). For myelinmaintenance experiments, sciatic nerves were harvested at 4 weeks or 4
months after the last tamoxifen injection. We isolated a 1-cm-long segment from each sciatic nerve distal to the crush site, which was marked
with powdered carbon. This 1-cm-long segment was cut in half; the more
proximal 0.5 cm segment was always used for transmission electron microscopy (TEM), while the more distal 0.5 cm segment was always used
for immunohistochemistry (IHC). These two halves of the nerve segment were drop-fixed in appropriate fixatives. The tissues were embedded such that the midpoint of the original 1 cm segment faced the front of
the block face for sectioning so that TEM and IHC images derive from
approximately the same distance (0.5 cm) from the crush site. For neuromuscular junction (NMJ) innervation experiments, extensor digitorum longus (EDL) muscles were isolated at 12 dpi from the legs of mice
whose sciatic nerves had been crushed as described above. EDL muscles
from the uncrushed contralateral sides were used as controls.
IHC staining. Sciatic nerves were isolated as described above, dropfixed in 4% paraformaldehyde (PFA) overnight at 4°C, and processed as
described previously (Mogha et al., 2013) for all stains except for Gpr126
and SCG10. For Gpr126 staining, nerves were drop-fixed in 4% PFA for
30 min at room temperature and then processed as described previously
(Giera et al., 2015). For EDL muscle, tissue was drop-fixed overnight at
4°C after sticking on a piece of a toothpick to avoid curling. After washing
with PBS, muscle was kept in 30% sucrose solution and then cryosectioned longitudinally at 20 m thickness. The following primary antibodies were used: rabbit anti-Gpr126 CTF (1:10; Petersen et al., 2015), rat
anti-MBP (1:10; Bio-Rad Laboratories), chicken anti-lacZ (1:400; Abcam), rabbit anti-c-Jun (1:400; Cell Signaling Technology), rabbit antis100 (1:400; Dako Cytomation), rat anti-CD68 (1:50; Abcam), rabbit
anti-Ki67 (1:400; Abcam), rabbit anti-SCG10 (1:2000; Shin et al., 2014),
goat anti-Iba1 (1:200; Abcam), and rabbit anti-NF-200 (1:500; SigmaAldrich). For NMJ stains, ␣-bungarotoxin (BTX)-Alexa Fluor 555 (Invitrogen) was used. After three washes in PBS, sections were incubated
with the appropriate fluorescently labeled secondary antibodies (1:1000;
Invitrogen) suspended in blocking buffer for 1 h at room temperature.
After further washing in PBS, slides were mounted using Vectashield
with DAPI (Vector Labs) to label nuclei. Fluorescent images were obtained with a Zeiss AxioImager M2 microscope.
Western blotting. Sciatic nerves were isolated from mice at 3 dpi. Segments of uninjured and distal injured sciatic nerve measuring 1 cm in
length were homogenized in lysis buffer (Cell Signaling Technology)
with protease and phosphatase inhibitors (Roche). Fifteen micrograms
of protein were loaded and analyzed by SDS-PAGE and western blot with
the following antibodies: rabbit anti-c-Jun (1:1000; Cell Signaling Technology), rabbit anti-␣ tubulin (1:20,000; Abcam), and goat anti-rabbit
IgG HRP (1:10,000; Life Technologies). Membranes were developed with
SuperSignal West Pico (Thermo Fisher Scientific), imaged on a ChemiDoc MP imaging system (Bio-Rad Laboratories), and quantified with
Image Lab 5.2.1 software (Bio-Rad Laboratories).
TEM. Sciatic nerves were isolated as described above, drop-fixed in
modified Karnovsky’s fixative (4% PFA and 2% glutaraldehyde in 0.1 M
sodium cacodylate, pH 7.4) at 4°C overnight, and processed as described

Mogha et al. • Gpr126/Adgrg6 in Peripheral Nerve Repair

previously (Monk et al., 2011). Semithin sections (200 –300 nm) were
stained with toluidine blue and viewed on a light microscope (Zeiss AxioImager M2). Images were recorded with an AxioCam MRm. Thin sections (70
nm) were stained with uranyl acetate and Sato’s lead stain and then viewed
on a Jeol (JEM-1400) electron microscope. Images were recorded with an
Advanced Microscopy Techniques V601 digital camera.
Bluo-gal staining. Mouse sciatic nerves were harvested as described
above and were postfixed in 2% PFA and 0.1% glutaraldehyde in 0.1 M
sodium cacodylate for 1 h at 4°C. Nerves were processed with the bluogal solution as described previously (Aoyama et al., 2004). Briefly, nerve
segments were incubated in bluo-gal solution (5 mM potassium ferricyanide plus 5 mM potassium ferrocyanide plus 2 mM MgCl2 plus 0.1%
5-bromo-3 indoyl-␤-D-galactoside) at 37°C for 20 h. Following this,
nerves were postfixed in 2% PFA and 2% glutaraldehyde in 0.1 M sodium
cacodylate overnight at 4°C. After this step, nerves were processed for
TEM as described previously (Monk et al., 2011)
Morphometric quantifications. To calculate g-ratios, we manually measured axon diameter and axon-plus-myelin diameter in ImageJ. We measured 100 axons from ⬃2200 m 2 regions of nerve selected at random
from N ⫽ 3 for control-injected or tamoxifen-injected animals at each
time point. The measurements were taken with the observer blind to
treatment.
To calculate axon regrowth index, longitudinal sciatic nerve sections
were made (7 m thick) at 3 dpi. These nerve sections were stained with
anti-SCG10 as described previously (Shin et al., 2012). We measured
distance of the longest SCG10⫹ axons from the crush site, measuring ⱖ5
axons within a 0.2 mm distance. The lengths were normalized to the
lengths of the corresponding sibling controls. We also counted the number of SCG10⫹ regenerated axons at standard distances from the crush
site. Axons were counted at 0.5 mm intervals starting at 1.5 mm from the
crush site. The number of axons at each given distance was normalized to
1 mm. Averages were taken at each spot and were compared between
control and tamoxifen groups for corresponding sites from the crush
sites. At least three animals per group were examined, and measurements
were taken with the observer blind to treatment or genotype.
To quantify myelin debris, we used ImageJ to define contours around
myelin debris in ⬃2200 m 2 regions of TEM micrographs, and contour
area was normalized to the total area. At least 10 randomly selected areas
were quantified from N ⫽ 3 animals per group, and measurements were
taken with the observer blind to treatment. For axon numbers, we similarly quantified the total axon number from ⬃2200 m 2 regions of TEM
micrographs. At least 10 randomly selected areas were quantified from
N ⫽ 3 animals per group, and measurements were taken with the observer blind to treatment.
To quantify molecular markers of SCs, proliferation, and macrophages, we manually counted the number of Ki67⫹ or c-Jun⫹ nuclei,
which were also positive for DAPI. The number of these nuclei was
normalized to the total number of nuclei in the field of view. Macrophages were counted as CD68⫹ or IBA1⫹ cells and the numbers were
normalized to the corresponding sibling control for each experiment.
For LacZ⫹ cells, we counted the LacZ⫹ cells manually and normalized
to the total number of SCs positive for S100. We used three animals for
each group in each experiment, and quantifications were performed with
the observer blind to treatment.
RNA extraction and reverse transcription. Total RNA was extracted
from single sciatic nerves that had been flash frozen in liquid nitrogen
using traditional three-phase separation with TRIzol (Life Technologies). Briefly, TRIzol was added to the frozen tissue samples, which were
then homogenized using the following steps: the nerves were first cut into
smaller pieces with dissection scissors, then disrupted with a plastictipped electric homogenizer, and finally passaged through a syringe and
successively smaller needles (22.5 and 27 g) 10 times each.
Total RNA (200 ng) was then reverse-transcribed in 20 l using
Superscript III First Strand Synthesis with random hexamers (Invitrogen). The reaction mixture was incubated for 5 min at 65°C, 50 min
at 50°C, and for 5 min at 85°C, as per the instructions from the
manufacturer. To control for genomic DNA contamination, a noreverse transcriptase reaction (RT⫺) was also performed for each
RNA sample.
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Quantitative reverse-transcription PCR. All assays were performed on a
ViiA7 (Applied Biosystems) qPCR machine with 2⫻ SsoFast Evagreen
Supermix (Applied Biosystems). Cycling parameters were 95°C (10 min)
followed by 40 cycles of 95°C (15 s), then 60°C (1 min) with a ramp speed
of 1°C/s. Melting curve analysis was completed as follows: 95°C (15 s),
60°C (1 min), and a progressive increase up to 95°C (0.5°C/min).
Myelin gene expression was assayed using the following previously published primers: Sox10: 5⬘-CAGGTGTGGCTCTGCCCACG-3⬘ and 5⬘GTGTAGAGGGGCCGCTGGGA-3⬘; Mbp: 5⬘-CCAAGTTCACCCCT
ACTCCA-3⬘ and 5⬘-TAAGTCCCCGTTTCCTGTTG-3⬘ (Sox10 and Mbp;
Finzsch et al., 2010); Oct6: 5⬘-TCGAGGTGGGTGTCAAAGG-3⬘ and 5⬘GGCGCATAAACGTCGTCCA-3⬘ (Zhu et al., 2014). Chemokine expression of 84 genes was evaluated using the 96-well format of the RT 2 Profiler
PCR Array: Chemokines and Receptors (mouse; Qiagen) for the ViiA7 machine. All qPCR data were analyzed using Microsoft Excel. Relative expression was calculated using the ⌬⌬Ct method (Livak and Schmittgen, 2001).
All samples were normalized to the average expression of several stably expressed housekeeping control genes: ActB, B2m, GapDH, GusB, and Hsp90.
Relative expression (RQ), or fold change (2 ⫺⌬⌬Ct), is shown in figures. Error
bars depict RQmax and RQmin, which are the maximum and minimum
limits of possible RQ values based on the SD of the ⌬Ct values. Three biological replicates for all genotypes and sibling controls were performed.
Statistical analyses. All data are presented as the mean ⫹ SD or ⫾ SD.
Significance is represented as *p ⬍ 0.05; **p ⬍ 0.01; ***p ⬍ 0.001. Sample
sizes are similar to those of previously published works. A minimum of
three animals per genotype were used unless otherwise noted. Statistical
analyses were performed using an unpaired Student’s t test with two tails
or using ANOVA as indicated and in accordance with previously published works. Unequal variance and datasets analyzed by a Student’s t test
met the appropriate assumptions, including normality.

Results
Inducible deletion of Gpr126 from mature SCs
Gpr126 is essential for SC development (Monk et al., 2009, 2011;
Mogha et al., 2013; Petersen et al., 2015), yet we previously noted
that Gpr126 is also highly expressed in mature SCs (Mogha et al.,
2013), indicating additional possible roles of this aGPCR in adult
nerve. To investigate the role of Gpr126 in the mature PNS, we
generated SC-specific, tamoxifen-inducible conditional knockout mice by crossing previously described Gpr126fl/fl mice
(Mogha et al., 2013) with mice expressing tamoxifen-inducible
Cre recombinase under control of the PLP promoter (Leone et
al., 2003). We also used the Rosa-LacZ locus as a reporter for Cre
activity. Gpr126fl/fl;PLPCre-ERT2;Rosa⫹ mice, hereafter referred to
as icKO mice, were injected once per day with 2 mg of tamoxifen
or vehicle control (nine parts sunflower oil plus one part ethanol)
at 8 weeks of age for 5 consecutive days. IHC analyses of sciatic
nerve cross sections 4 weeks after injection using anti-Gpr
126 and LacZ antibodies revealed that the majority of SCs in
tamoxifen-injected animals are Gpr126(⫺) and LacZ(⫹) (Fig.
1B; N ⫽ 3 animals). Some SCs are Gpr126(⫹) following tamoxifen administration, but all Gpr126(⫹) SCs are LacZ(⫺) (Fig.
1B), indicating that Cre was not activated in these cells.
Gpr126 deletion does not affect myelin maintenance up to
4 months.
Having established that tamoxifen administration effectively deletes Gpr126 from mature SCs, we next sought to use this model
to determine whether Gpr126 is required for remyelination after
injury. Given that we have recently determined that loss of
Gpr126 in SCs leads to axon– glial interaction defects after ⬃1
year of age (Küffer et al., 2016), we wanted to test whether Gpr126
is required for myelin maintenance in the short term (e.g., at time
points to be examined in nerve-injury studies). To this end, we
examined sciatic nerves of tamoxifen-injected and control-
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Figure 1. PLPCre-ERT2 drives recombination of Gpr126 in mature SCs. A, B, IHC shows Gpr126 protein levels in icKO mice 4 weeks after control (A) or tamoxifen (B) injections. A–Aⴖ, Gpr126 (red)
is observed in SCs from control-injected sciatic nerve (arrows), but LacZ (green) is not, indicating a lack of Cre activity. B–B”, Gpr126 (red) is not observed in recombined LacZ(⫹) (green) SCs (red
arrows), demonstrating that PLPCre-ERT2 can effectively delete Gpr126 from mature SCs. Some Gpr126(⫹) cells are observed (white arrows), but do not costain for LacZ, indicating that Cre was not
active. DAPI (blue) labels nuclei. Scale bar: (in B) A, B, 50 m. C, Schematic representation of experimental approach in icKO mice.

injected icKO mice 4 weeks after injection. We did not observe
differences between the two groups in the levels of myelin basic
protein (MBP) by IHC (Fig. 2 A, B; N ⫽ 3 for each group), and
LacZ staining again demonstrated robust Cre activity in
tamoxifen-injected animals (Fig. 2 A, B). Consistent with this observation, toluidine blue staining of semithin (200 –300 nm) sections showed no obvious differences in morphology between
tamoxifen-injected and control-injected icKO animals at 4 weeks
(Fig. 2C,D; N ⫽ 3 for each group). We next counted the number

of SC nuclei 4 weeks after injection to determine whether the SC
number is affected by the loss of Gpr126 and did not observe any
significant difference in the number of SC nuclei (Fig. 2G; N ⫽ 3
for each group). Quantitative reverse-transcription PCR (qPCR)
analysis on the sciatic nerves for mature SC markers (Sox10, Oct6,
and Mbp) revealed no significant change in the expression levels
of these genes 4 weeks after injection (Fig. 2H ). Finally, ultrastructural analyses by TEM further demonstrated that there
are no differences in myelin ultrastructure or thickness in
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Figure 2. Gpr126 is dispensable for maintenance of MBP protein levels and gross myelin morphology up to 4 months. A–Bⴖ, IHC of sciatic nerve cross sections stained with MBP (red), LacZ (green),
and DAPI (blue) 4 weeks following final control (A–Aⴖ) or tamoxifen (B–Bⴖ) injections. Scale bar: (in A), A–Bⴖ, 50 m. C–F, Toluidine blue stained semithin sections of control-injected (C, E) and
tamoxifen-injected (D, F ) animals reveal no gross differences 4 weeks (C, D) or 4 months (E, F ) following the final injections. Scale bar: (in C) C–F, 20 m. G, Number of SC nuclei is not significantly
different in tamoxifen-injected animals compared with controls 4 weeks after injection. H, qPCR 4 weeks after tamoxifen injection reveals that expression of key SC differentiation genes (Sox10, Oct6,
Mbp) is not significantly altered between the two groups. Error bars are shown as ⫾SD.

tamoxifen-injected versus control-injected icKO mice 4 weeks
following the final injection (Fig. 3 A, C, E, G; N ⫽ 3 for each
group, p ⫽ 0.19, ANOVA). These data support the notion that
Gpr126 is not required for myelin maintenance up to 1 month,
consistent with previous observations in zebrafish (Glenn and
Talbot, 2013).
To determine whether deletion of Gpr126 from SCs affects
longer-term myelin maintenance, we expanded our analysis to 4
months after tamoxifen injections. Similar to 4 weeks after injection, MBP levels and nerve morphology are not affected in icKO
Gpr126 mutants compared with controls as assessed by IHC (data
not shown) and toluidine blue-stained semithin sections, respectively (Fig. 2 E, F; N ⫽ 3 for each group). Moreover, TEM analyses
again revealed no obvious differences in myelin ultrastructure or
thickness in tamoxifen-injected versus control-injected icKO
mice (Fig. 3 B, D, F, H; N ⫽ 3 for each group, p ⫽ 0.13, ANOVA).
Together, these data suggest that Gpr126 is dispensable for my-

elin maintenance up to 4 months; thus, we were able to perform
nerve-injury studies without confounding effects on Gpr126dependent PNS maintenance.
Remyelination is impaired in inducible Gpr126 mutants
To further dissect the function of Gpr126 in mature nerve, we
next investigated its necessity in remyelination following nerve
injury. To this end, we crushed the sciatic nerves of tamoxifeninjected or control-injected icKO mice 4 weeks after the last injection and analyzed the nerves at 21 dpi (N ⫽ 3 for each group).
By this time point in control nerves, myelin debris has been
largely cleared, axons have regrown, and redifferentiated SCs are
robustly remyelinating regenerated axons (Akassoglou et al.,
2002). To ensure valid comparisons between the experimental
groups, we marked the crush site at the time of injury with powdered carbon, and we analyzed distal sciatic nerve segments at the
same distance from the crush site (5 mm).
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Figure 3. Gpr126 is dispensable for myelin maintenance up to 4 months. A–D, TEM micrographs of sciatic nerves from control-injected (A, B) and tamoxifen-injected (C, D) icKO animals 4 weeks
(A, C) and 4 months (B, D) following the final injection. No gross differences were observed in either treatment or time point. Scale bar: (in A) A–D, 2 m. E–H, Quantification of g-ratio in
control-injected (black) and tamoxifen-injected (gray) icKO animals at 4 weeks (E, G) and 4 months (F, H ) following the final injection. G-ratio quantification reveals no significant difference
between the two groups 4 weeks after injections ( p ⫽ 0.19, ANOVA) or at 4 months after injections ( p ⫽ 0.13, ANOVA). Error bars are shown as ⫾SD.

Toluidine blue-stained semithin sections and TEM analyses
show that nerves from control-injected icKO mice are robustly
remyelinated with little myelin debris persisting (Fig. 4 A, C,E). In
contrast, remyelination is significantly impaired in sciatic nerves
from tamoxifen-injected icKO mice as assessed by toluidine
blue-stained semithin sections (Fig. 4B). TEM analyses further
revealed many defects at the ultrastructural level in tamoxifeninjected icKO mice at 21 dpi (Fig. 4D), including significantly
more myelin debris (Fig. 4D, black arrows, E; p ⫽ 5.7 ⫻ 10 ⫺13,

Student’s t test), large-caliber axons (⬎1 m) in bundles (Fig.
4D, asterisks), aberrant SC cytoplasmic protrusions (Fig. 4D,
white arrows), and fewer myelinated axons (Fig. 4F; p ⫽ 2.3 ⫻
10 ⫺8, Student’s t test). G-ratio analyses revealed that the remyelinated axons observed in the tamoxifen-injected icKO animals
have thinner myelin (i.e., higher g-ratios) compared with
control-injected animals (Fig. 4G,H; p ⫽ 0.00006, ANOVA). Importantly, IHC staining with MBP and LacZ showed that myelin
debris-like figures were associated with LacZ(⫹) SCs (Fig. 5B,
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Figure 4. Remyelination is impaired in inducible Gpr126 mutants. A, B, Toluidine blue-stained semithin sciatic nerve sections reveal impaired remyelination in tamoxifen-injected icKO animals
(B) compared with control animals (A) 21 dpi. Scale bar: (in A) A, B, 20 m. C, D, TEM micrographs of control-injected (C) or tamoxifen-injected (D) icKO sciatic nerves at 21 dpi. Axons in control
nerves are well myelinated. In tamoxifen-injected icKO sciatic nerves, myelin debris is evident (D, black arrows), few axons are myelinated, large caliber axons are observed in bundles (D, asterisks),
and SC cytoplasmic protrusions are observed (D, white arrows). Scale bar: (in C) C, D, 2 m. E, F, Quantification of nerve abnormalities in control-injected (black) versus tamoxifen-injected (gray)
icKO animals at 21 dpi. E, More area is covered by myelin debris in tamoxifen-injected icKO mice compared with controls ( p ⫽ 5.8 ⫻ 10 ⫺13, Student’s t test). F, Fewer axons are myelinated in
tamoxifen-injected compared with control-injected icKO animals ( p ⫽ 2.3 ⫻ 10 ⫺08, Student’s t test). G, H, G-ratio analyses show that when remyelination occurs in tamoxifen-injected animals,
the myelin sheaths are thinner than in control-injected animals ( p ⫽ 0.003, ANOVA). Error bars are shown as ⫾SD.

arrowheads), while myelin rings with normal morphology were
not associated with LacZ(⫹) SCs (Fig. 5B, asterisks). This indicates that Gpr126(⫹) SCs are capable of remyelination, while
Gpr126(⫺) SCs are not, supporting the model that Gpr126 is

required SC-autonomously for remyelination. To more conclusively demonstrate that the LacZ(⫹) cells we observed in
tamoxifen-injected animals are incapable of remyelination, we
performed bluo-gal staining on the sciatic nerves at 21 dpi before
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Figure 5. Gpr126 in SCs is required for remyelination at 21 dpi. A, B, IHC of sciatic nerve cross sections at 21 dpi in control-injected (A) and tamoxifen-injected (B) animals stained with MBP (red),
LacZ (green), and DAPI (blue). Robust MBP stain in control animals reveals that most myelin rings have normal morphology. In tamoxifen-injected animals, MBP stain with abnormal morphology
is associated with LacZ(⫹) SCs (arrowheads), while MBP stain with normal morphology is associated with LacZ(⫺) SCs (asterisks). C–Dⴕ, Bluo-gal EM staining of nerves at 21 dpi reveals that the
myelinated axons observed in tamoxifen-treated nerves are associated with bluo-gal(⫺) SCs that therefore lack Cre activity (D, asterisks). In contrast, bluo-gal(⫹) SCs (identified by deposition of
electron dense bluo-gal reaction residue, arrowheads) have persistent myelin debris. Box in D shown magnified in Dⴕ. Scale bars: (in B) A–Bⴖ, 50 m; (in C) C, D, 2 m.

TEM analysis. This causes bluo-gal crystals to form in LacZ(⫹)
cells, which can be visualized by TEM (Aoyama et al., 2004). This
approach showed that bluo-gal(⫹) SCs (Fig. 5 D, D⬘, black arrows) are filled with myelin debris and have not remyelinated,
whereas we never observed bluo-gal crystals in SCs that have
remyelinated (Fig. 5D, asterisks).
To determine whether remyelination impairments in tamoxifeninjected icKO animals are transient, we analyzed the sciatic nerves
from control-injected and tamoxifen-injected icKO mice at 35 dpi
(Fig. 6). We again performed bluo-gal staining before TEM analysis
to identify SCs with or without Cre activity. We observed that even at
35 dpi, remyelination was impaired in tamoxifen-injected animals
(Fig. 6B). There were some myelinated axons present (Fig. 6B, asterisks), but these were always associated with bluo-gal(⫺) SCs. In contrast, axons associated with bluo-gal(⫹) SCs were unmyelinated,
often with myelin debris still present (Fig. 6B, arrows). Together,
these data indicate that Gpr126 is required autonomously in SCs for
remyelination.
Gpr126 is not required for demyelination or c-Jun elevation
in repair SCs following injury
Consistent with the essential role of Gpr126 in SC developmental
myelination, we propose that this aGPCR is similarly required for
remyelination following injury. Beyond this role, however, we
note that cellular responses to nerve injury and subsequent regeneration are complex and highly controlled. Thus, the impaired remyelination we observe in inducible Gpr126 mutants
could also in part be attributable to several, nonmutually exclusive causes. Following nerve injury, SCs transform into dedicated
repair cells that degrade myelin by a selective form of autophagy
termed “myelinophagy” (Gomez-Sanchez et al., 2015), macrophages are recruited to aid in myelin debris clearance, and axons
must regrow through SC/basal lamina tubes found distal to the
injury (Chen et al., 2007). Therefore, we sought to further investigate each stage of injury and repair to define the function(s) of
Gpr126 in peripheral regeneration. First, we analyzed nerves at 3

dpi by TEM and IHC staining. At this early time point after
injury, robust demyelination, repair SC generation, and myelin/
axonal debris clearance should be evident (Jessen and Mirsky,
2008; Arthur-Farraj et al., 2012; Jessen et al., 2015). Neither toluidine blue-stained semithin sections nor TEM micrographs
revealed overt differences between tamoxifen-injected or
control-injected icKO mice (Fig. 7A–D), and both groups had
similar amounts of myelin debris (Fig. 7E; N ⫽ 3, p ⫽ 0.91,
Student’s t test). These data suggest that Gpr126 is not required in
SCs for demyelination following injury.
Next, we examined the ability of SCs lacking Gpr126 to elevate
c-Jun. After injury, this transcription factor is required in SCs for
downregulation of mature SC genes, for transformation into repair SCs, and c-Jun can be used as a molecular marker of repair
SCs (Arthur-Farraj et al., 2012; Jessen et al., 2015). We observed
no differences in c-Jun(⫹) nuclei by IHC in control-injected
versus tamoxifen-injected animals at 3 dpi (Fig. 8A–C; N ⫽ 3, p ⫽
0.85, Student’s t test). Additionally, Ki67 staining revealed
that proliferation was not affected in control-injected versus
tamoxifen-injected icKO mice at 3 dpi (data not shown). Western
blot analysis demonstrated that c-Jun was indeed elevated in
tamoxifen-injected icKO nerves at 3 dpi, although levels were
slightly lower than those of control-injected nerves (Fig. 8 D, E;
N ⫽ 4, p ⫽ 0.02). Tamoxifen-injected icKO animals possess both
mutant and unrecombined wild-type SCs, which could affect
quantitative analysis of protein levels. Therefore, we next
examined c-Jun levels in SC-specific conditional knock-out
Gpr126fl/fl;DhhCre⫹ mice in which Gpr126 is deleted at ⬃E12.5
(Mogha et al., 2013). The Gpr126fl/fl;DhhCre⫹ mice are hereafter
referred to as “cKO” animals. qPCR for the transcription factor
Sox10, which marks all SCs, revealed no significant differences
between control and cKO animals 3 dpi (Fig. 8F ). Western blot
analyses showed that, without injury, c-Jun levels in some cKO
mice were slightly higher than in wild-type siblings (Fig. 8G,H;
N ⫽ 6, p ⫽ 0.003; see below). Importantly, however, upregulation of total c-Jun is not affected negatively in cKO animals at 3
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Figure 6. Gpr126 in SCs is required for remyelination at 35 dpi. A, B, TEM images at 35 dpi of sciatic nerve cross sections from control-injected (A) or tamoxifen-injected (B) mice. Myelin debris
persists and is associated only with SCs possessing bluo-gal crystals (B, arrows). In contrast, SCs lacking bluo-gal crystals are associated with myelin (B, asterisk). C–E, Quantifications show the
percentage LacZ(⫹) (gray bars) or LacZ(⫺) (black bars) SCs with the indicated characteristics. C, More LacZ(⫹) SCs are associated with myelin debris compared with LacZ(⫺) SCs ( p ⫽ 0.002,
Student’s t test). D, More LacZ(⫹) SCs are observed at the promyelinating stage than LacZ(⫺) SCs ( p ⫽ 0.007, Student’s t test). E, Only LacZ(⫺), and never LacZ(⫹) SCs, are observed at the
myelinating stage. N ⫽ 4.

Figure 7. Demyelination is not impaired in inducible Gpr126 mutants following injury. A, B, Toluidine blue-stained semithin sciatic nerve sections reveal grossly equal demyelination in
tamoxifen-injected icKO animals (B) compared with control animals (A) at 3 dpi. Scale bar: (in A) A, B, 50 m. C, D, TEM micrographs of control-injected (C) or tamoxifen-injected (D) icKO sciatic
nerves at 3 dpi. Scale bar: (in C) C, D, 2 m. E, Quantification reveals no significant differences in the area covered by myelin debris in control-injected (black bar) versus tamoxifen-injected (gray bar)
icKO animals ( p ⫽ 0.914, Student’s t test). Error bars are shown as ⫾SD.
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Figure 8. Gpr126 is not required for c-Jun induction in SCs following injury. A–Bⴕ, IHC of sciatic nerve cross sections at 3 dpi in control-injected (A, Aⴕ) and tamoxifen-injected (Bⴕ)
animals stained with LacZ (green), c-Jun (red), and DAPI (blue). Both LacZ(⫹) (white arrows) and LacZ(⫺) (red arrows) SCs are c-Jun(⫹), indicating that SCs upregulate c-Jun normally
in the presence or absence of Gpr126. Scale bar: (in B) A–Bⴕ, 20 m. C, Quantification reveals no difference in the number of c-Jun(⫹) nuclei in control-injected (black bar) versus
tamoxifen-injected (gray bar) icKO animals ( p ⫽ 0.85, Student’s t test). D, Western blot analysis of sciatic nerve without (⫺) and with (⫹) nerve injury shows that tamoxifen-injected
icKO animals upregulate c-Jun at 3 dpi, although to a variably lesser extent than control-injected animals. Results from N ⫽ 2 control and N ⫽ 2 tamoxifen-injected animals are shown.
E, Quantification of c-Jun levels in control-injected (black bars) versus tamoxifen-injected (gray bars) icKO nerves 3 dpi (⫾nerve crush). Results are quantified from N ⫽ 4 controlinjected and N ⫽ 4 tamoxifen-injected animals [p ⫽ 0.02 control-injected (⫹) nerve crush vs tamoxifen-injected (⫹) nerve crush, Student’s t test]. F, qPCR analysis shows that Sox10
expression is not significantly different in wild-type (WT; black bar) versus SC-specific cKO Gpr126fl/fl;DhhCre⫹ mice (cKO animals, gray bar; p ⫽ 0.93, Student’s t test). G, Western blot
analysis of cKO nerves compared with wild-type sibling (WT) nerves at 3 dpi reveals that c-Jun is upregulated in both groups after injury. Results from N ⫽ 3 WT and N ⫽ 3 cKO animals
are shown. H, Quantification of c-Jun levels in WT (black bars) versus cKO (gray bars) nerves at 3 dpi (⫾nerve crush). Results are quantified from N ⫽ 6 WT and N ⫽ 6 cKO animals [p ⫽
0.001, WT (⫹) nerve crush vs cKO (⫹) nerve crush, Student’s t test]. Error bars are shown as ⫾SD.

dpi, and indeed levels were higher in these mutants compared
with wild-type siblings (Fig. 8G,H; N ⫽ 6, p ⫽ 0.001, Student’s t
test). Together, these data support the notion that Gpr126 is
dispensable for acquisition of some characteristics of the repair
SC, namely demyelination, proliferation, and c-Jun activation.

Gpr126 is required in SCs for macrophage recruitment to the
peripheral nerve following injury
Although SCs themselves can clear significant myelin debris in
the distal stump of injured peripheral nerves (Perry et al., 1995;
Niemi et al., 2013; Gomez-Sanchez et al., 2015), blood-derived
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Figure 9. Macrophage recruitment is delayed in inducible Gpr126 mutants following injury. A, IHC of sciatic nerve cross sections in control-injected (A, Aⴕ, D, Dⴕ, G, Gⴕ) and tamoxifen-injected
(B, Bⴕ, E, Eⴕ, H, Hⴕ) icKO animals stained with CD68, s100 (green), and DAPI (blue) at indicated stages, and (J–Qⴕ) IHC staining with Iba1 (red), S100 (green) and DAPI (blue) at 3 (J–Kⴕ), 7 (M–Nⴕ),
and 21 dpi (P–Qⴕ), respectively. Scale bar: (in A) A–Bⴕ, D–Eⴕ, G–Hⴕ, J–Qⴕ, 50 m. C, F, I, Quantification reveals a significant decrease in the number of CD68(⫹) macrophages in tamoxifen-injected
(gray bar) versus control-injected (black bar) icKO animals at 3 (C; p ⫽ 8.33 ⫻ 10 ⫺05, Student’s t test) and 7 dpi (F; p ⫽ 1.99 ⫻ 10 ⫺08, Student’s t test), but not at 21 dpi (I; p ⫽ 0.82, Student’s
t test). L, O, R, Similarly, the number of Iba1(⫹) cells is significantly higher in control nerves at 3 (L; p ⫽ 0.0004, Student’s t test) and 7 dpi (O; p ⫽ 0.0015, Student’s t test), but not at 21 dpi (R; p ⫽
0.59, Student’s t test). Error bars are ⫾SD.

macrophages, which are in part recruited by SCs, are also key
players in myelin debris clearance and peripheral nerve repair
following injury (Martini et al., 2008; Chen et al., 2015). To test
whether loss of Gpr126 in SCs impairs macrophage numbers, we
performed IHC with macrophage markers (CD68 and Iba-1) on
distal sciatic nerves of control-injected and tamoxifen-injected
icKO mice at different time points after injury (3, 7, and 21 dpi;
Fig. 9). We counted the number of CD68(⫹) or Iba-1(⫹) cells at
all time points in control-injected versus tamoxifen-injected
nerves. Quantification revealed a significant decrease in the number of CD68(⫹) macrophages in tamoxifen-injected versus
control-injected icKO animals at 3 (Fig. 9C; p ⫽ 8.33 ⫻ 10 ⫺05,
Student’s t test) and 7 dpi (Fig. 9F; p ⫽ 1.99 ⫻ 10 ⫺08, Student’s t
test), but not at 21 dpi (Fig. 9I; p ⫽ 0.82, Student’s t test). Simi-

larly, the number of Iba1(⫹) cells is significantly higher in control nerves at 3 (Fig. 9L; p ⫽ 0.0004, Student’s t test) and 7 dpi
(Fig. 9O; p ⫽ 0.0015, Student’s t test), but not at 21 dpi (Fig. 9R;
p ⫽ 0.59, Student’s t test). To further dissect the role of SCderived Gpr126 in macrophage recruitment, we again used cKO
mice in which Gpr126 is deleted in SCs from embryonic day 12.5
(Mogha et al., 2013). IHC analysis of cKO nerves at 3 dpi revealed
that, similar to icKO nerves, macrophage numbers are significantly reduced compared with the wild-type nerves (Fig. 10A–F;
C, p ⫽ 0.01, Student’s t test; F, p ⫽ 0.00054, Student’s t test).
These data reveal an unexpected role for SC-derived Gpr126 in
proper recruitment of macrophages following nerve injury.
Previous work has shown that after peripheral nerve injury,
repair SCs secrete a variety of chemokines to recruit macrophages
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Figure 10. Macrophage recruitment and chemokine expression are impaired in conditional knock-out Gpr126 mutants following injury. A–Bⴕ, D–Eⴕ, IHC for CD68 (A–Bⴕ) and Iba1 (D–Eⴕ) show
macrophages (red) in wild-type (WT; A, Aⴕ, D, Dⴕ) and cKO (B, Bⴕ, E, Eⴕ) nerves at 3 dpi. Scale bar: (in A) A–Eⴕ, 50 m. C, F, Quantification of CD68(⫹) cells (C) and Iba1(⫹) cells (F ) reveals that
the macrophage number is significantly decreased in cKO (gray bars) compared with WT (black bars). C, p ⫽ 0.01, Student’s t test; F, p ⫽ 0.00054, Student’s t test. G, Chemokine expression is
significantly reduced in Gpr126 cKO nerves at 3 dpi relative to controls (Ccl2, p ⫽ 0.0442; Ccl3, p ⫽ 0.0375, Cxcl10, p ⫽ 0.0244, Tnf, p ⫽ 0.0144, Student’s t test). Error bars are ⫾SD.

to the injury site (Martini et al., 2008; Brosius Lutz and Barres,
2014). Therefore, we hypothesized that Gpr126 is required for
chemokine expression after injury, and that the reduced infiltration of macrophages in Gpr126 mutants might be due to decreased chemokine expression by SCs. To begin to test this
hypothesis, we compared the expression of a wide range of
chemokines and their receptors between control and cKO nerves

(N ⫽ 3) at 3 dpi by qRT-PCR. For these experiments, we used
cKO nerves because preliminary microarray analyses of icKO
nerves (⫾tamoxifen) indicated that there was not clear separation between experimental groups by PCA plot analysis, possibly
due to the “contamination” of wild-type, unrecombined SCs in
these tissues. Thus, cKO mice represent the best available tool
with which to begin to dissect differential cytokine expression
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Figure 11. Axon regeneration is impaired when SCs lack Gpr126. A, B, IHC of longitudinal sections of crushed sciatic nerves stained with SCG10 at 3 dpi revealed that SCG10(⫹) axons extend
farther in control-injected (A) compared with tamoxifen-injected (B) icKO animals (white arrows). Crush sites are marked with white vertical lines. Scale bar: (in B) A, B, 500 m. C, D, Quantifications
reveal that axon regeneration is significantly impaired in tamoxifen-injected compared with control-injected icKO animals. C, Lengths of longest axons are shorter in tamoxifen-injected (gray bar)
icKO animals compared with control-injected (black bar) icKO animals ( p ⫽ 2.207 ⫻ 10 ⫺11, Student’s t test). D, Numbers of regenerated SCG10⫹ axons at defined distances from the crush site
are significantly lower in tamoxifen-injected icKO animals (gray bars) compared with control animals (black bars; p ⫽ 0.003 at 1.5 mm; 0.003 at 2 mm; 0.01 at 2.5 mm; 0.01 at 3 mm; 0.02 at 3.5 mm;
0.002 at 4 mm; 0.03 at 4.5 mm; 0.01 at 5 mm from the crush site; Student’s t test for each point). E, F, IHC of longitudinal sections of crushed sciatic nerves stained with SCG10 at 3 dpi revealed that
SCG10(⫹) axons extend farther in wild-type (WT; E) compared with cKO mutants (F; white arrows). Crush sites are marked with white vertical lines. Scale bar: (in B) E, F, 500 m. G, H,
Quantifications reveal that axon regeneration is significantly impaired in cKO Gpr126 mutants compared with WT littermates. G, Lengths of longest axons are shorter in cKO (gray bar) animals
compared with WT (black bar) animals ( p ⫽ 0.002, Student’s t test). H, Numbers of regenerated SCG10⫹ axons at 3 dpi is significantly lower in cKO mice (gray bars) compared with WT controls
(black bars; p ⫽ 0.02 at 1.5 mm; 0.01 at 2 mm; 0.006 at 2.5 mm; 0.002 at 3 mm; 0.0005 at 3.5 mm; 0.0004 at 4 mm; 0.01 at 4.5 mm; 0.01 at 5 mm from the crush site. Student’s t test for each point).
Error bars are shown as ⫾SD.

between wild-type and Gpr126 mutant SCs following injury. Of
the 84 genes tested, four chemokines were significantly downregulated in cKO nerves: Ccl2, Ccl3, Cxcl10, and Tnf (Fig. 9G).
Importantly, Ccl2 (Toews et al., 1998; Taskinen and Röyttä, 2000)
and Tnf (Chernov et al., 2015) are both normally upregulated
after peripheral nerve injury. Additionally, Tnf is important for
the immunological activation of SCs (Qin et al., 2008; Mao et al.,
2010), and Ccl2 is required for macrophage recruitment after
peripheral nerve injury (Toews et al., 1998). Interestingly, of the
four significant hits, Tnf is the most downregulated in Gpr126
mutant nerves, and previous studies have shown that Tnf is required for inducing the expression of Ccl2 (Chen et al., 2004; Lin
et al., 2007; Ho et al., 2008; Xia et al., 2011), Ccl3 (Wang et al.,
2012), and Cxcl10 (Hardaker et al., 2004; Qi et al., 2009) in other
contexts. To ensure that chemokine gene expression is not altered
in cKO SCs without injury, we repeated the chemokine array
analysis to compare uninjured cKO sciatic nerves with wild-type
controls at 8 weeks of age. Of the 84 tested genes, only MapK1 was
slightly (1.5-fold) upregulated in uninjured cKO nerves compared with controls (data not shown, N ⫽ 3, p ⫽ 0.04, Student’s
t test). Additionally, we observed no difference in macrophage
number in cKO sciatic nerves compared with wild-type sibling
control nerves at 8 weeks of age (data not shown). Together, these
data suggest that Gpr126 is required for inducing expression of
Tnf to activate the expression of chemokines by repair SCs to
recruit peripheral macrophages after nerve injury.
Gpr126 is required in SCs for proper axon regeneration
following injury
Following myelin and axonal debris clearance in the distal portion of an injured nerve, regenerating axons grow through tracts
called Büngner bands, which contain SCs and their original basal
laminae (Chen et al., 2007; Jessen et al., 2015). Given that Gpr126
has two known basal lamina binding partners— collagen IV

(Paavola et al., 2014) and laminin-211 (Petersen et al., 2015)—
and that aGPCRs have adhesive functions as well as signaling
functions (Langenhan et al., 2013), we reasoned that Büngner
bands, and subsequently axon regeneration, might be impaired
following loss of Gpr126 in SCs. To test this, we performed IHC
on longitudinal sections at 3 dpi with an anti-superior cervical
ganglion 10 (SCG10) antibody to selectively label regenerating
axons (Cho et al., 2013; Shin et al., 2014). SCG10 levels rapidly
decline in distal axons following injury, accumulate in proximal
axons within 1 h following injury, and are maintained during
axon regeneration (Shin et al., 2014). We observed that axon
regeneration is significantly impaired in tamoxifen-injected
icKO mice compared with control-injected mice (Fig. 11A–D) by
measuring the lengths of the longest SCG10(⫹) axons (Fig. 11C;
N ⫽ 3, p ⫽ 2.2 ⫻ 10 ⫺13, Student’s t test) as well as SCG10(⫹)
axon numbers at standard intervals from the crush site (Fig. 11D;
N ⫽ 3, p values given in figure legend). This analysis suggested
that Gpr126 in SCs is required for axon regeneration. However,
myelin debris clearance is impaired in icKO mice (Fig. 4E), which
could potentially affect axon regeneration. To control for this, we
next injured sciatic nerves of cKO mice. As cKO SCs never form
myelin (Mogha et al., 2013), no myelin debris can be present
following injury. Similar to icKO mice, we observed significantly
impaired axon regeneration by anti-SCG10 staining 3 dpi in cKO
mice compared with littermate Gpr126fl/fl;DhhCre⫺ controls (Fig.
11E–H; N ⫽ 3 for cKO, N ⫽ 4 for controls, p ⫽ 0.002 for length
of the longest axon, Student’s t test; p values for axon numbers at
standard distances from the crush site given in figure legend).
Next, we wanted to determine whether the observed axon
regeneration defects were transient; however, SCG-10 staining is
only effective for regenerating axons up to ⬃3 dpi (Shin et al.,
2014). Therefore, we instead examined NMJ innervation of the
EDL muscle, which is innervated by the sciatic nerve, at 12 dpi.
We stained NMJ end plates with BTX and counterstained axons
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Figure 12. NMJ reinnervation is impaired when Gpr126 is absent in SCs. A–C, NMJ staining with Alexa-555-conjugated BTX (red) and NF-200 (green) reveals that significantly fewer NMJs are
reinnervated at 12 dpi (white arrows) in tamoxifen-injected animals (B–Bⴖ) compared with control-injected animals (A–Aⴖ; N ⫽ 3, p ⫽ 0.05, Student’s t test). D–F, Significantly fewer NMJs are
reinnervated at 12 dpi in cKO mice (F–Fⴖ) compared with wild-type (WT) siblings (D–Dⴖ; N ⫽ 3, p ⫽ 0.003, Student’s t test). Scale bar: (in B) A–Bⴖ, D–Eⴖ, 50 m. Error bars are shown as ⫾SD.

with NF-200 (Cho et al., 2013, 2015). This analysis revealed that
even at 12 dpi, the number of NMJs occupied by NF-200(⫹) axons
was significantly lower in tamoxifen-injected animals compared
with control-injected animals (Fig. 12A–C; N ⫽ 3, p ⫽ 0.05, Student’s t test), although contralateral uninjured NMJ innervation was
unaffected (data not shown). We observed a similar phenotype in
cKO EDL muscle compared with wild-type siblings (Fig. 12D–F;
N ⫽ 3, p ⫽ 0.003, Student’s t test), again with contralateral NMJs
unaffected (data not shown). Together, these results suggest that
Gpr126 is nonautonomously required in SCs for peripheral axon
regeneration following nerve injury.

Discussion
In regeneration as in development, the peripheral nerve is a complex organ that requires interactions and communication between many cell types for proper function. SCs “sense” axon
injury by an unknown mechanism, and as Wallerian degeneration and subsequent axon regeneration proceed, SCs respond
with remarkable plasticity. Mature phenotypes are lost and the
cells are transformed into dedicated repair SCs that play many
roles in nerve repair and functional recovery. Repair SCs clear
debris and recruit macrophages to the distal stump. Repair SC
morphology drastically flattens and elongates (Arthur-Farraj et
al., 2012), but the basal lamina that once encompassed the mature
SC persists. Repair SCs form longitudinal columns within the

basal lamina tubes, and these units are collectively referred to as
Büngner bands. Regenerating axons grow through Büngner
bands and require extracellular matrix cues and trophic support
from repair SCs for their migration and survival (Chen et al.,
2007; Brosius Lutz and Barres, 2014). Finally, SCs further demonstrate their capacity for dramatic change by once more acquiring mature phenotypes, and in the case of myelinating SCs, by
remyelinating the regenerated axons.
Although the signals that regulate remyelination are not completely understood, many developmental pathways are reinitiated (Chen et al., 2007). The aGPCR Gpr126 is essential for
developmental myelination (Monk et al., 2009, 2011; Mogha et
al., 2013) and, intriguingly, Gpr126 mRNA and protein are maintained in mature SCs (Mogha et al., 2013; Fig. 1). Although
prolonged loss of Gpr126 in SCs is associated with abnormal
axon– glial interactions after ⬃1 year (Küffer et al., 2016), our
data suggest that Gpr126 is dispensable for myelin maintenance
up to 4 months after deletion (Figs. 2, 3). The lack of a myelin
maintenance phenotype up to 4 months following loss of Gpr126
permitted us to perform nerve-injury studies without confounding homeostatic impairments. We noted a significant reduction
in the number of remyelinated axons and persistence of myelin
debris at 21 dpi (Fig. 4 B, D–F ), and our marker and TEM analyses suggested that Gpr126(⫹) SCs were capable of proper remy-
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elination while Gpr126(⫺) SCs were not (Figs. 5, 6). In addition
to this SC-autonomous function in remyelination, we also observed interesting non-SC-autonomous phenotypes in icKO and
cKO mutants following injury; namely, reduced macrophage recruitment and impaired axon regeneration (Figs. 9 –12).
Following nerve injury, repair SCs upregulate several chemokines, including interleukins, TNF-␣, leukemia inhibitory factor,
and MCP-1, which serve to recruit macrophages to the distal
nerve (Martini et al., 2008; Brosius Lutz and Barres, 2014). These
macrophages phagocytose myelin and axonal debris, and are key
for facilitating eventual nerve repair (Brück, 1997; Martini et al.,
2008; Chen et al., 2015). Interestingly, here we show that Gpr126
is required in SCs to upregulate chemokine expression following
nerve injury, particularly Tnf and some of its downstream targets—Ccl2, Ccl3, and Cxcl10 (Fig. 10G). Dissecting the molecular
relationships between Gpr126 and these chemokines in macrophage recruitment will be an important next step as will determining how reduced macrophage numbers directly affect repair
in this model. Despite their importance, however, macrophages
are not completely essential for debris clearance in the distal
stump, as repair SCs are also highly proficient at this task. Indeed,
for the first 5 d following injury (Liu et al., 1995; Perry et al.,
1995), SCs are primarily responsible for debris clearance and, in
mouse mutants that lack macrophage recruitment to distal nerve
due to loss of the chemokine receptor Ccr2, SCs are capable of
clearing myelin debris alone (Niemi et al., 2013). It was recently
shown that repair SCs clear myelin debris by a specialized form
of autophagy termed “myelinophagy” (Gomez-Sanchez et al.,
2015). Therefore, our observation that myelin debris persists up
to 21 dpi (Fig. 4E) suggests that Gpr126 is also required in SCs for
efficient myelinophagy, and future work is required to directly
test this hypothesis.
We also observed impaired axon regeneration and NMJ reinnervation in SC-specific Gpr126 mutants that was not the consequence of increased myelin debris, as both icKO (myelin debris
present) and cKO mutants (myelin debris absent) displayed the
same phenotype (Figs. 11, 12). Given that the extracellular matrix
proteins laminin-211 and collagen IV are binding partners for
Gpr126 (Paavola et al., 2014; Petersen et al., 2015), it is possible
that the Büngner band basal lamina tubes are disrupted without
Gpr126 in such a way that axon regeneration is inhibited. Although we did not observe obvious loss of the basal lamina by
TEM, abnormal basal lamina loops and outfoldings were evident
in Gpr126 icKO mutants up to 21 dpi (Fig. 4D), suggesting that
the stability of this structure was in some way compromised. We
note that laminin proteins are known modulators of axon regeneration following nerve injury. Antibody-mediated perturbation
of the ␣2-laminin chain reduces axon regeneration on nerve sections, while genetic loss of the ␥1-laminin chain impairs axon
regeneration in vivo (Agius and Cochard, 1998; Chen and Strickland, 2003). Thus, perhaps Gpr126 and laminin-211 interactions
are required in regeneration in addition to development. Interestingly, loss of c-Jun in SCs also impairs axon regeneration in
addition to neuronal survival (Arthur-Farraj et al., 2012). c-Jun is
a transcription factor that functions as a key mediator of repair
SC transformation following injury, although c-Jun levels are
upregulated in Gpr126 mutant SCs after nerve crush (Fig. 8). In
the future, it will be important to investigate whether c-Junindependent/Gpr126-dependent pathways in SCs are required
for nerve repair.
In SC development, a major pathway downstream of Gpr126
activation is the elevation of cAMP to initiate terminal differentiation (Monk et al., 2009, 2011; Mogha et al., 2013). Whereas a
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driving role for cAMP in SC differentiation has been known for
decades (Mokuno et al., 1988; Monuki et al., 1989; Mirsky et al.,
1990; Morgan et al., 1991; Scherer et al., 1994), the function of
this second messenger in the injury response is less clear, as previous studies draw different conclusions regarding levels of
cAMP in distal nerve stumps following injury. cAMP levels were
reported to be increased 1– 6 h after nerve-crush injury in rabbit
(Appenzeller and Palmer, 1972) and decreased 2–35 d after cut or
crush injury in rats (Podulso et al., 1995). There are also conflicting reports regarding the effect of exogenous cAMP elevation on
nerve repair (McQuarrie et al., 1977; Gershenbaum and Roisen,
1980), and cAMP certainly functions in peripheral axons in addition to SCs (Kilmer and Carlsen, 1984, 1987). Given that
Gpr126 can couple to Gi-family proteins in addition to Gs
(Mogha et al., 2013; Liebscher et al., 2014) and that Gpr126 has
G-protein signaling-independent functions in SCs (Petersen et
al., 2015), we cannot conclude that a lack of cAMP elevation
underlies any of the phenotypes we observe in the SC-specific
Gpr126 mutants following injury. Indeed, it is perhaps counterintuitive that such a strong differentiation signal would be required in SCs
while they are maintaining a repair, nondifferentiated phenotype,
although we predict that cAMP elevation is required for remyelination following re-establishment of axon–SC interactions in repair as
in development. As the sensitivity and in vivo applications for cAMP
sensors improve (Langenhan et al., 2015), it will be very interesting
to monitor cAMP levels in individual SCs following nerve injury and
during repair responses and remyelination.
In neurobiology, aGPCRs have traditionally been studied in
the context of development (Langenhan et al., 2016), but here we
demonstrate key functions for Gpr126 in nerve regeneration in
the adult animal. We show that Gpr126 is required in SCs for
axon remyelination, mirroring its essential developmental role.
We also show that SC-derived Gpr126 is needed for proper macrophage recruitment, myelin debris clearance, and axon regeneration, uncovering new and unexpected roles for this aGPCR in
peripheral nerve repair. As a GPCR, Gpr126 represents an attractive therapeutic target in PNS disease and injury, and given the
link between Gpr126 and laminin 211, this work has important
clinical implications for MDC1A patients.
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